Short answer
CVRx, Inc. (CVRX) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $15M (up 9.8% year over year) with net income of −$13M.
Q3 2025 key financials · XBRL
- Revenue
- $15M
- +9.8% YoY · +8.1% QoQ
- Net income
- −$13M
- +1.7% YoY · +12.7% QoQ
- Operating margin
- -83.5%
- Gross margin
- 86.8%
- EPS (diluted)
- −$0.49
- +69.4% YoY · +14.0% QoQ
Source: XBRL data from the CVRx, Inc. (CVRX) Q3 2025 10-Q on SEC EDGAR. USD.
CVRx, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $14.7M, up 10% YoY from $13.4M, driven by U.S. revenue of $13.5M, up 10%
- Gross margin 87% vs 83% YoY, supported by higher average selling price and lower unit costs
- Europe fastest-growing geography, revenue $1.2M, up 12% YoY; U.S. revenue $13.5M, up 10%
- Cash $85.1M vs $105.9M at December 31, 2024; nine-month operating cash outflow $30.4M
- $9.5M gross ATM proceeds during nine months; $50.0M outstanding term loans; continued losses expected for several years
Risk Factors
- New risk: European foreign-regulatory compliance, triggered by Barostim’s MDR approval and ongoing conformity obligations
- Most material update: MDR certificates for Barostim technical file and quality system issued April 9, 2025
- Compliance risk: Annual Notified Body audits and substantial-change reviews could result in CE Certificate suspension or withdrawal
- Operational risk: Barostim Legacy remains under prior-device approval only through December 31, 2027
- Carried-forward risks: No material changes reported beyond the newly added European regulatory factor
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CVRx, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.